Abstract:Constitutively active KRAS mutations have been found to be involved in various processes of cancer development, and render tumor cells resistant to EGFR-targeted therapies. Mutation detection methods with higher sensitivity will increase the possibility of choosing the correct individual therapy. Here, we established a highly sensitive and efficient microfluidic capillary electrophoresis-based restriction fragment length polymorphism (µCE-based RFLP) platform for low-abundance KRAS genotyping with the combination of µCE and RFLP techniques. By using our self-built sensitive laser induced fluorescence (LIF) detector and a new DNA intercalating dye YOYO-1, the separation conditions of µCE for ΦX174 HaeIII DNA marker were first optimized. Then, a Mav I digested 107-bp KRAS gene fragment was directly introduced into the microfluidic device and analyzed by µCE, in which field amplified sample stacking (FASS) technique was employed to obtain the enrichment of the RFLP digestion products and extremely improved the sensitivity. The accurate analysis of KRAS statuses in HT29, LS174T, CCL187, SW480, Clone A, and CX-1 colorectal cancer (CRC) cell lines by µCE-based RFLP were achieved in 5 min with picoliter-scale sample consumption, and as low as 0.01% of mutant KRAS could be identified from a large excess of wild-type genomic DNA (gDNA). In 98 paraffin-embedded CRC tissues, KRAS codon 12 mutations were discovered in 28 (28.6%), significantly higher than that obtained by direct sequencing (13, 13.3%). Clone sequencing confirmed these results and showed this system could detect at least 0.4% of the mutant KRAS in CRC tissue slides. Compared with direct sequencing, the new finding of the µCE-based RFLP platform was that KRAS mutations in codon 12 were correlated with the patient's age. In conclusion, we established a sensitive, fast, and cost-effective screening method for KRAS mutations, and successfully detected low-abundance KRAS mutations in clinical samples, which will allow provision of more precise individualized cancer therapy.

Single-Nucleotide-Specific Lipidic Nanoflares for Precise and Visible Detection of KRAS Mutations via Toehold-Initiated Self-Priming DNA Polymerization

Stimuli-Induced Upgrade of Nuclease-Resistant DNA Nanostructure Composed of a Single Molecular Beacon for Detecting Mutant Genes

CRISPR/Cas12a Bio-Assay Integrated with Metal-Organic Framework Based Enhanced Fluorescent Labels for Ultrasensitive Detection of Circulating Tumor DNA

Fe-Au Nanoparticle-Coupling for Ultrasensitive Detections of Circulating Tumor DNA

Design of peptide nucleic acid probes on plasmonic gold nanorods for detection of circulating tumor DNA point mutations

Single-molecule detection of cancer mutations using a novel PCR-LDR-qPCR assay

A sensitive fluorescence anisotropy method for point mutation detection by using core-shell fluorescent nanoparticles and high-fidelity DNA ligase.

Overhang Molecular Beacons Encapsulated in Tethered Cationic Lipoplex Nanoparticles for Detection of Single-Point Mutation in Extracellular Vesicle-Associated RNAs.

Toehold-mediated Strand Displacement Reaction Triggered Isothermal DNA Amplification for Highly Sensitive and Selective Fluorescent Detection of Single-Base Mutation.

Ultrasensitive single-nucleotide polymorphism detection using target-recycled ligation, strand displacement and enzymatic amplification.

Loopback Rolling Circle Amplification for Ultrasensitive Detection of Kras Gene

Dna Terminal Structure-Mediated Enzymatic Reaction For Ultra-Sensitive Discrimination Of Single Nucleotide Variations In Circulating Cell-Free Dna

The fluorescence amplification strategy based on 3D DNA walker and CRISPR/Cas12a for the rapid detection of BRAF V600E

Label-free Fluorescent Sensor for Sensitive Detection of Ctdna Based on Water Stabilized CsPbBr3 Nanosheet

Development of a Hybridization Chain Reaction-Powered Lab-on-fiber Device for Ultrafast Point-of-care Testing of Circulating Tuor DNA in Whole Blood.

Upconversion Nanoparticle and Gold Nanocage Satellite Assemblies for Sensitive Ctdna Detection in Serum.

Detection of Low-Abundance KRAS Mutations in Colorectal Cancer Using Microfluidic Capillary Electrophoresis-Based Restriction Fragment Length Polymorphism Method with Optimized Assay Conditions.

Detection of Circulating Tumor DNA in Human Blood Via DNA-Mediated Surface-Enhanced Raman Spectroscopy of Single-Walled Carbon Nanotubes.

Integrating Cycled Enzymatic DNA Amplification and Surface-Enhanced Raman Scattering for Sensitive Detection of Circulating Tumor DNA

Label-free fluorescent sensor for sensitive detection of ctDNA based on water stabilized CsPbBr 3 nanosheet

Palindromic Molecular Beacon-Based Intramolecular Strand-Displacement Amplification Strategy for Ultrasensitive Detection of K-ras Gene.